InvestIdeas

not vested

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide.

It operates through two segments, LabCorp Diagnostics and Covance Drug Development.

The company offers a range of clinical laboratory tests and procedures, as well as specialty testing services in the areas of allergy, diagnostic genetics, women's health, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and pain management; and esoteric testing, cancer diagnostics, and other complex procedures.

In addition, the company provides drug development solutions to the pharmaceutical and biotechnology industries, as well as laboratory testing services.

Source: Today's Big Stock

http://todaysbigstock.com/2016/09/16/la ... s-nyse-lh/

not vested

AMERICA'S AGING POPULATION IS SENDING THESE SHARES HIGHER

Today's chart highlights a big shift in the health care sector...

As regular readers know, our colleague David Eifrig is bullish on health care stocks. All Baby Boomers will be older than 65 by 2030, according to the U.S. Census Bureau. That means 1 in five citizens will be of retirement age. And they'll likely be making more visits to the doctor...

That's where Laboratory Corporation of America (LH) comes in. The $19 billion company, best known as LabCorp, is the world's leading diagnostics firm. It operates its own network of medical laboratories, providing services like blood tests, urinalyses, and at-home testing kits.

And it seems an influx of aging patients is already driving growth... LabCorp brought in more than $2.8 billion of revenue in the first quarter, an 18% year-over-year increase.

For shareholders, the upside of this trend speaks for itself. LabCorp's stock has climbed nearly 50% over the past two years, recently hitting a new all-time high.

As America's elderly population grows, health care stocks should continue to climb...

Source: Daily Wealth

not vested

A TAILWIND FOR ONE OF THE WORLD'S DIAGNOSTICS LEADERS

Today, we're taking a look at a company that thrives as folks get older...

Regular readers know our colleague Dr. David Eifrig believes that health care stocks will benefit as the Baby Boomer generation continues to age.

And as the Boomers get older, the need to monitor their health becomes more important. That's where today's company comes in...

Laboratory Corporation of America (LH) is a global leader in drug development and diagnostic testing. However, most of its sales are based in the U.S.

While the company has emerged as a key player during the COVID-19 pandemic, it also works to treat and analyze diseases like cancer, Alzheimer's, and diabetes...

And as of its most recent annual results in 2019, its revenues have increased every year for the past five years.

As you can see, LH shares have surged in recent months. The stock is up roughly 125% since its March lows, and it just hit an all-time high. As long as LabCorp continues to provide quality research to treat the aging American population, this stock should continue higher...

Source: Daily Wealth

Indeed a very solid one.
Watchlist towards earnings 10/2.
Expectations may be hard to beat.